Matthew Doogue

4.6k total citations · 2 hit papers
94 papers, 3.1k citations indexed

About

Matthew Doogue is a scholar working on Endocrinology, Diabetes and Metabolism, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Matthew Doogue has authored 94 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Endocrinology, Diabetes and Metabolism, 20 papers in Pediatrics, Perinatology and Child Health and 12 papers in Pharmacology. Recurrent topics in Matthew Doogue's work include Pharmacological Effects and Toxicity Studies (12 papers), Pharmacogenetics and Drug Metabolism (11 papers) and Pharmaceutical studies and practices (10 papers). Matthew Doogue is often cited by papers focused on Pharmacological Effects and Toxicity Studies (12 papers), Pharmacogenetics and Drug Metabolism (11 papers) and Pharmaceutical studies and practices (10 papers). Matthew Doogue collaborates with scholars based in New Zealand, Australia and United States. Matthew Doogue's co-authors include Thomas M. Polasek, Richard O. Day, Jerry R. Greenfield, Peter Timmins, Garry G. Graham, Janna K. Duong, John E. Ray, Carl M. J. Kirkpatrick, Manit Arora and Timothy J. Furlong and has published in prestigious journals such as Journal of the American College of Cardiology, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Matthew Doogue

85 papers receiving 3.1k citations

Hit Papers

Clinical Pharmacokinetics of Metformin 2011 2026 2016 2021 2011 2015 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical Pharmacokinetics of Metformin
    2011 979 citations Richard O. Day, Matthew Doogue et al. profile →
  2. Relative Hyperglycemia, a Marker of Critical Illness: Introducing the Stress Hyperglycemia Ratio
    2015 326 citations Stephen Quinn, Morton G. Burt et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Doogue New Zealand 25 976 757 525 371 360 94 3.1k
Suodi Zhai China 32 778 0.8× 772 1.0× 490 0.9× 497 1.3× 260 0.7× 181 3.5k
Diane K. Wysowski United States 31 844 0.9× 630 0.8× 371 0.7× 216 0.6× 354 1.0× 49 3.8k
Donald A. Wiebe United States 29 752 0.8× 463 0.6× 487 0.9× 283 0.8× 297 0.8× 67 3.8k
Loes E. Visser Netherlands 36 775 0.8× 913 1.2× 723 1.4× 331 0.9× 418 1.2× 124 4.3k
Kyung‐Sang Yu South Korea 32 609 0.6× 918 1.2× 599 1.1× 663 1.8× 597 1.7× 333 4.5k
Robert J. Straka United States 30 437 0.4× 709 0.9× 542 1.0× 505 1.4× 179 0.5× 109 2.6k
Lynda Frassetto United States 37 336 0.3× 849 1.1× 566 1.1× 471 1.3× 522 1.4× 108 4.8k
Stephan Krähenbühl Switzerland 32 347 0.4× 988 1.3× 446 0.8× 344 0.9× 233 0.6× 100 3.1k
Kim Dalhoff Denmark 32 341 0.3× 582 0.8× 319 0.6× 508 1.4× 455 1.3× 194 3.6k
Annalisa Capuano Italy 41 1.0k 1.0× 1.1k 1.5× 747 1.4× 532 1.4× 547 1.5× 266 5.8k

Countries citing papers authored by Matthew Doogue

Since Specialization
Citations

This map shows the geographic impact of Matthew Doogue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Doogue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Doogue more than expected).

Fields of papers citing papers by Matthew Doogue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Doogue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Doogue. The network helps show where Matthew Doogue may publish in the future.

Co-authorship network of co-authors of Matthew Doogue

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Doogue. A scholar is included among the top collaborators of Matthew Doogue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Doogue. Matthew Doogue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doogue, Matthew, Mei Zhang, Julia J. Rucklidge, et al.. (2025). Investigation of a broad‐spectrum micronutrient formulation as a possible precipitant of pharmacokinetic micronutrient–drug interactions. British Journal of Clinical Pharmacology. 91(7). 1987–1995.
2.
Chin, Paul K. L., Kellie A. Charles, Bridin Murnion, et al.. (2023). Evaluation of the Prescribing Skills Assessment implementation, performance and medical student experience in Australia and New Zealand. British Journal of Clinical Pharmacology. 89(10). 3105–3115. 4 indexed citations
3.
Drake, Ross, Sungwon Chang, Jane Hunt, et al.. (2023). Gabapentin for Pain in Pediatric Palliative Care. Journal of Pain and Symptom Management. 67(3). 212–222.e1. 2 indexed citations
4.
Seah, Davinia, Andrew Wilcock, Sungwon Chang, et al.. (2022). Paracentesis for cancer-related ascites in palliative care: An international, prospective cohort study. Palliative Medicine. 36(9). 1408–1417. 5 indexed citations
5.
Chang, Sungwon, Jane Hunt, Matthew Doogue, et al.. (2022). Pharmacovigilance in hospice/palliative care: Net effect of amitriptyline or nortriptyline on neuropathic pain: UTS/IMPACCT Rapid programme international consecutive cohort. Palliative Medicine. 36(6). 938–944. 5 indexed citations
6.
7.
Palmer, D. G., Steven Soule, Ravinder Reddy Gaddam, et al.. (2020). Unbound vitamin D concentrations are not decreased in critically ill patients. Internal Medicine Journal. 52(1). 89–94. 5 indexed citations
8.
Maggo, Simran, Eng Wee Chua, Paul K. L. Chin, et al.. (2017). A New Zealand platform to enable genetic investigation of adverse drug reactions.. PubMed. 130(1466). 62–69. 8 indexed citations
9.
10.
Khong, Jwu Jin, Kathryn P. Burdon, Yi Lu, et al.. (2016). Pooled genome wide association detects association upstream of FCRL3 with Graves’ disease. BMC Genomics. 17(1). 939–939. 10 indexed citations
11.
Sanderson, Christine, Stephen Quinn, Meera Agar, et al.. (2016). Pharmacovigilance in hospice/palliative care: net effect of pregabalin for neuropathic pain. BMJ Supportive & Palliative Care. 6(3). 323–330. 6 indexed citations
12.
Doogue, Matthew, et al.. (2013). Allopurinol use in pregnancy in three women with inflammatory bowel disease: safety and outcomes: a case series. BMC Gastroenterology. 13(1). 172–172. 9 indexed citations
13.
Lin, Frank, Stephen M. Anthony, Thomas M. Polasek, Guy Tsafnat, & Matthew Doogue. (2011). BICEPP: an example-based statistical text mining method for predicting the binary characteristics of drugs. BMC Bioinformatics. 12(1). 112–112. 4 indexed citations
14.
Whiting, Malcolm J. & Matthew Doogue. (2009). Advances in biochemical screening for phaeochromocytoma using biogenic amines.. PubMed Central. 27 indexed citations
15.
Hooper, Amanda J., et al.. (2009). Extreme diabetic lipaemia associated with a novel lipoprotein lipase gene mutation. Clinica Chimica Acta. 406(1-2). 167–169. 8 indexed citations
16.
Parasca, Adrian D., Matthew Doogue, Richard Woodman, & Arduino A. Mangoni. (2009). Hypoalbuminaemia and impaired renal function are associated with increased anticholinergic drug prescribing. International Journal of Clinical Practice. 63(7). 1110–1114. 6 indexed citations
17.
Doogue, Matthew, Evan J. Begg, M. Peter Moore, et al.. (2009). Metformin increases plasma ghrelin in Type 2 diabetes. British Journal of Clinical Pharmacology. 68(6). 875–882. 29 indexed citations
18.
Polasek, Thomas M., Sebastian Polak, Matthew Doogue, Amin Rostami‐Hodjegan, & John O. Miners. (2009). Assessment of inter-individual variability in predicted phenytoin clearance. European Journal of Clinical Pharmacology. 65(12). 1203–1210. 15 indexed citations
19.
Doogue, Matthew, Evan J. Begg, & Paul Bridgman. (2005). Clopidogrel Hypersensitivity Syndrome With Rash, Fever, and Neutropenia. Mayo Clinic Proceedings. 80(10). 1368–1370. 21 indexed citations
20.
Doogue, Matthew, et al.. (1998). Has the prognosis for left main (LM) and left main equivalent (LMEQ) coronary disease changed: analysis of a long waiting list. Journal of the American College of Cardiology. 31. 214–215. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suodi Zhai Breakdown of academic impact, for papers by Diane K. Wysowski Breakdown of academic impact, for papers by Donald A. Wiebe Breakdown of academic impact, for papers by Loes E. Visser Breakdown of academic impact, for papers by Kyung‐Sang Yu Breakdown of academic impact, for papers by Robert J. Straka Breakdown of academic impact, for papers by Lynda Frassetto Breakdown of academic impact, for papers by Stephan Krähenbühl Breakdown of academic impact, for papers by Kim Dalhoff Breakdown of academic impact, for papers by Annalisa Capuano
Rankless by CCL
2026